Minerva Neurosciences Inc Total Liabilities

Latest as of March 2026: $348.04 Million USD

Minerva Neurosciences Inc total liabilities. Based on the latest financial reports, Minerva Neurosciences Inc (NERV) has total liabilities worth $348.04 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Minerva Neurosciences Inc (NERV) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Minerva Neurosciences Inc (2012–2025)

Total liabilities of Minerva Neurosciences Inc from 2012 to 2025. This chart illustrates how Minerva Neurosciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Minerva Neurosciences Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Minerva Neurosciences Inc Competitors by Total Liabilities

The table below lists competitors of Minerva Neurosciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Sam Young Chem KO:003720	Korea	₩112.72 Billion
Apyx Medical Inc NASDAQ:APYX	USA	$49.98 Million
MTM Critical Metals Ltd AU:MTM	Australia	AU$13.94 Million
Besiktas Futbol Yatirimlari Sanayi ve Ticaret AS IS:BJKAS	Turkey	TL23.00 Billion
Humanica Public Company Limited BK:HUMAN	Thailand	฿553.69 Million
San Lien Technology TWO:5493	Taiwan	NT$2.82 Billion
Orthocell Ltd AU:OCC	Australia	AU$20.67 Million
Noroo Paint KO:090350	Korea	₩343.45 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Minerva Neurosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NERV total asset value.

Liquidity & Leverage Metrics

Minerva Neurosciences Inc Total Liabilities Ratios Explained

Minerva Neurosciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	17.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.70	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Minerva Neurosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Minerva Neurosciences Inc (2012–2025)

The table below shows the annual total liabilities of Minerva Neurosciences Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	$238.72 Million	+279.90%
2024-12-31	$62.84 Million	-26.38%
2023-12-31	$85.36 Million	+13.64%
2022-12-31	$75.11 Million	+8.63%
2021-12-31	$69.15 Million	+1293.06%
2020-12-31	$4.96 Million	-90.02%
2019-12-31	$49.72 Million	+1.74%
2018-12-31	$48.87 Million	-6.20%
2017-12-31	$52.10 Million	+93.25%
2016-12-31	$26.96 Million	-1.09%
2015-12-31	$27.26 Million	+60.80%
2014-12-31	$16.95 Million	+88.44%
2013-12-31	$9.00 Million	+4627.09%
2012-12-31	$190.29K	--

About Minerva Neurosciences Inc

NASDAQ:NERV USA Biotechnology

Market Cap

$109.48 Million

Market Cap Rank

#18640 Global

#4343 in USA

Share Price

$2.35

Change (1 day)

+0.21%

52-Week Range

$2.20 - $8.07

All Time High

$117.60